BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Rapid Micro Biosystems Announces the 2013 Availability of Growth Direct(TM) Systems for Environmental Monitoring and Sterility Applications


4/16/2012 11:23:24 AM

BEDFORD, MA--(Marketwire - April 16, 2012) -

Rapid Micro Biosystems, the provider of rapid, automated, non-destructive detection and enumeration technologies in microbiology, today announced the 2013 availability of the next generation of Growth Direct™ applications. The tests are specifically designed for environmental monitoring and sterility applications in pharmaceutical quality control laboratories. Representing a quantum leap from the current sterility and environmental monitoring test methods, the applications are based on the detection of natural auto-fluorescence of microorganisms. The Growth Direct™ System requires no additional reagents to detect growing colonies.

The Growth Direct™ System for Environmental Monitoring automates the high volume testing typically found in the combination of air, surface and personnel monitoring.

  • Two results in one: Positive results in hours, with continued incubation for final results in half the time of the compendial method.
  • Large capacity: Designed to handle high numbers of samples per day.
  • Added efficiency: Automated reading of all environmental monitoring tests and data transfer to laboratory information systems (LIMS) frees resources for higher value activities.
  • Actionable reporting: System alerts users immediately and trending analysis uncovers developing problems.
  • Non-destructive: Analysis is non-destructive, allowing for microbial identification.

The Growth Direct™ System for Sterility revolutionizes pharmaceutical microbial quality control testing while adhering to the stringent regulatory requirements of sterility testing. Features of the system include the following:

  • Positive results in hours: Early, real-time detection of microbial contamination, allowing for faster response to contamination events.
  • Non-destructive test: Samples with positive results can continue to grow for additional analysis of the micro organism colony.
  • Closed-loop sample prep: Aseptic sample preparation and testing of both aerobic and anaerobic microbes.
  • 7 days versus 14: The typical sterility test requires 14 days. The Growth Direct™ for Sterility will provide final results in about half the time.
  • Quantitative results: An actual colony count (in colony forming units) is provided at the end of the test, with regular count updates throughout the test.

These new applications build on the existing Growth Direct™ technology currently used in FDA regulated manufacturing facilities. As with the Growth Direct™ System for Water and Bioburden, sample preparation mimics the existing method including the ability to integrate to a laboratory information management system (LIMS). Once samples are loaded, the system uses the natural auto-fluorescence of the living cells to automatically analyze and enumerate any growing colonies. User configurable software allows for the creation of alerts on out-of-specification samples, with reporting in colony forming units (CFUs.) The test is non-destructive and uses no reagents, ensuring the availability of the sample for identification.

"These new applications for automated, rapid sterility and environmental monitoring testing address critical microbial quality control testing needs in pharmaceutical manufacturing. Businesses will be able to react quickly to contamination events while increasing productivity and standardizing their QC processes," said Steve Delity, President and CEO of Rapid Micro Biosystems.

The new systems and applications will be available in the first half of 2013.


Contact:
Mark Severns
Rapid Micro Biosystems
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->